We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves First-Ever Interchangeable Biosimilar Insulin, Signaling New Day in Pricing
FDA Approves First-Ever Interchangeable Biosimilar Insulin, Signaling New Day in Pricing
The FDA has approved the first-ever interchangeable biosimilar insulin product, which could signal the beginning of the end for the soaring costs of insulin products.